Immunohematology - Medical Devices Pipeline Assessment, 2019

Published by Global Data on 14th November 2019 | Ref: 1464186 | This Product Is In Stock

$2500 | Single User
$5000 | Site License
$7500 | Enterprise License
$2500 | Single User
$5000 | Site License
$7500 | Enterprise License


Immunohematology - Medical Devices Pipeline Assessment, 2019


GlobalData's Medical Devices sector report, “Immunohematology - Medical Devices Pipeline Assessment, 2019" provides an overview of Immunohematology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunohematology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.


- Extensive coverage of the Immunohematology under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Immunohematology and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to -

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Immunohematology under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Table of Contents

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Immunohematology Overview 6

3 Products under Development 7

3.1 Immunohematology - Pipeline Products by Stage of Development 7

3.2 Immunohematology - Pipeline Products by Segment 8

3.3 Immunohematology - Pipeline Products by Territory 9

3.4 Immunohematology - Pipeline Products by Regulatory Path 10

3.5 Immunohematology - Pipeline Products by Estimated Approval Date 11

4 Immunohematology - Pipeline Products under Development by Companies 12

4.1 Immunohematology Companies - Pipeline Products by Stage of Development 12

4.2 Immunohematology - Pipeline Products by Stage of Development 13

5 Immunohematology Companies and Product Overview 14

5.1 AbSorber AB Company Overview 14

5.2 Alba Bioscience Limited Company Overview 15

5.3 Amity University Company Overview 17

5.4 Arizona State University Company Overview 18

5.5 Biofortuna Ltd Company Overview 19

5.6 Grifols SA Company Overview 24

5.7 Ortho-Clinical Diagnostics Inc Company Overview 25

5.8 Quotient Ltd Company Overview 27

5.9 Transfusion & Transplantation Technologies (Inactive) Company Overview 30

6 Immunohematology- Recent Developments 35

6.1 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 35

6.2 Nov 01, 2019: Haemonetics reports 2nd quarter and 1st half fiscal 2020 results; raises fiscal 2020 adjusted operating margin and adjusted EPS guidance 37

6.3 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 39

6.4 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 40

6.5 Oct 14, 2019: Biocare Medical appoints Nicolas Barthelemy as Executive Chairman 41

6.6 Sep 24, 2019: Theradiag announces improved results for H1 2019 41

6.7 Sep 12, 2019: Haemonetics Appoints Stewart W. Strong As President, Global Hospital 44

6.8 Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement 45

6.9 Aug 29, 2019: Siemens Healthineers announces new Canadian leadership 45

6.10 Aug 06, 2019: Haemonetics reports 1st Quarter Fiscal 2020 results, updates Fiscal 2020 earnings guidance and launches operational excellence program 46

7 Appendix 98

7.1 Methodology 98

7.2 About GlobalData 101

7.3 Contact Us 101

7.4 Disclaimer 101

Additional Details


Global Data

Publisher Information


1464186 | GDME0816EPD

Number of Pages


Report Format


Related Reports

Date Published
Price From

This report is published by Global Data

Global Data deliver comprehensive, detailed market intelligence that provides a definitive picture of the markets they serve. Their data is complete, detailed, global and completely cross-country comparable.

With different types of data other providers don’t provide, our clients can access a variety of tools that add context to our core data including innovation tracking, sentiment analysis, price monitoring, M&A tracking, competitor intelligence, and city-level intelligence.

Download Free Report Summary PDF

Immunohematology - Medical Devices Pipeline Assessment, 2019 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.